Internal Medicine, Pulmonary Disease · Miami, FL
NPI
1508852674
Since 2005
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
198 NW 37th Ave Fl 2
Miami, FL, 33125
Phone (305) 267-5544
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
1,599 services
Medicare patients, 2024
318
Average age 79
Drug cost, 2024
$850K
2,060 prescriptions
Company payments, 2025
$1,049
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jorge M Ortega was code 99232 (hospital e&m - subsequent), 631 times for 161 patients. In total Jorge M Ortega billed 1,599 services in 29 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 631 | 161 | $68.31 | $43K |
| 99231 Hospital E&M - Subsequent | Facility | 350 | 121 | $43.66 | $15K |
| 99214 Office E&M - Established | Office | 95 | 63 | $106.44 | $10K |
| 94003 E&M - Miscellaneous | Facility | 57 | 15 | $56.16 | $3,201 |
| 99222 Hospital E&M - Initial | Facility | 53 | 52 | $112.49 | $5,962 |
| 99223 Hospital E&M - Initial | Facility | 48 | 48 | $150.53 | $7,226 |
| 99213 Office E&M - Established | Office | 44 | 43 | $77.02 | $3,389 |
| 94060 Pulmonary Function Testing | Office | 37 | 37 | $32.84 | $1,215 |
| 94729 Pulmonary Function Testing | Office | 37 | 37 | $47.85 | $1,771 |
| 94727 Pulmonary Function Testing | Office | 37 | 37 | $37.82 | $1,399 |
| 99233 Hospital E&M - Subsequent | Facility | 21 | 14 | $102.65 | $2,156 |
| 99204 Office E&M - New | Office | 14 | 14 | $146.50 | $2,051 |
By year: 2022 $194K for 2,952 services; 2023 $155K for 2,087 services; 2024 $110K for 1,599 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jorge M Ortega prescribed most often to Medicare patients was Montelukast Sodium, with 344 prescriptions and refills. In total Jorge M Ortega wrote 2,060 Medicare prescriptions that cost $850K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 344 | 611 | 98 | $1,706 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 265 | 295 | 65 | $186K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 262 | 293 | 74 | $6,992 |
| Breo Ellipta Fluticasone/Vilanterol | 114 | 150 | 31 | $59K |
| Atrovent Hfa Ipratropium Bromide | 96 | 102 | 25 | $47K |
| Ipratropium-Albuterol Ipratropium/Albuterol Sulfate | 95 | 95 | Under 11 | $3,301 |
| Prednisone Generic | 87 | 100 | 35 | $355 |
| Fluticasone Propionate Generic | 82 | 133 | 32 | $1,012 |
| Ventolin Hfa Albuterol Sulfate | 74 | 81 | 20 | $4,763 |
| Azithromycin Generic | 58 | 58 | 42 | $146 |
| Methylprednisolone Generic | 58 | 58 | 44 | $420 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 57 | 60 | 17 | $29K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 53 | 54 | 13 | $25K |
| Spiriva Respimat Tiotropium Bromide | 46 | 52 | Under 11 | $26K |
| Symbicort Budesonide/Formoterol Fumarate | 42 | 50 | 11 | $12K |
Brand drugs: 1,091 claims; generic drugs: 969 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jorge M Ortega $1,049 ($1,049 in general payments such as food, travel and fees) from 9 companies. The largest payer was Genzyme Corporation with $418.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 9 | $418 |
| Verona Pharma, Inc. VRNA | 8 | $205 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $102 |
| Insmed, Inc. INSM | 3 | $64.1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62.02 |
| Viatris Specialty LLC | 3 | $60.18 |
| GlaxoSmithKline, LLC. GSK | 2 | $56.3 |
| Paratek Pharmaceuticals, Inc. | 2 | $48.63 |
| Lilly USA, LLC LLY | 2 | $32.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.